Cargando…
Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968880/ https://www.ncbi.nlm.nih.gov/pubmed/33626235 http://dx.doi.org/10.1002/cac2.12150 |
| _version_ | 1783666133376696320 |
|---|---|
| author | Yi, Jun Ho Kim, Seok Jin Yoon, Dok Hyun Suh, Cheolwon Chang, Myung Hee Yang, Deok Hwan Jo, Jae‐Cheol Hyun, Shin Young Eom, Hyeon‐Seok Lee, Jeong‐Ok Kwon, Ji Hyun Han, Sang Hoon Lee, Seung‐Shin Kwak, Jae‐Yong Kim, Se Hyung Kim, Dae Sik Lee, Ji Hyun Oh, Sung Yong Ryoo, Hun Mo Kim, Hyo Jung Kim, Won Seog |
| author_facet | Yi, Jun Ho Kim, Seok Jin Yoon, Dok Hyun Suh, Cheolwon Chang, Myung Hee Yang, Deok Hwan Jo, Jae‐Cheol Hyun, Shin Young Eom, Hyeon‐Seok Lee, Jeong‐Ok Kwon, Ji Hyun Han, Sang Hoon Lee, Seung‐Shin Kwak, Jae‐Yong Kim, Se Hyung Kim, Dae Sik Lee, Ji Hyun Oh, Sung Yong Ryoo, Hun Mo Kim, Hyo Jung Kim, Won Seog |
| author_sort | Yi, Jun Ho |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7968880 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79688802021-03-19 Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis Yi, Jun Ho Kim, Seok Jin Yoon, Dok Hyun Suh, Cheolwon Chang, Myung Hee Yang, Deok Hwan Jo, Jae‐Cheol Hyun, Shin Young Eom, Hyeon‐Seok Lee, Jeong‐Ok Kwon, Ji Hyun Han, Sang Hoon Lee, Seung‐Shin Kwak, Jae‐Yong Kim, Se Hyung Kim, Dae Sik Lee, Ji Hyun Oh, Sung Yong Ryoo, Hun Mo Kim, Hyo Jung Kim, Won Seog Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2021-02-24 /pmc/articles/PMC7968880/ /pubmed/33626235 http://dx.doi.org/10.1002/cac2.12150 Text en © 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Yi, Jun Ho Kim, Seok Jin Yoon, Dok Hyun Suh, Cheolwon Chang, Myung Hee Yang, Deok Hwan Jo, Jae‐Cheol Hyun, Shin Young Eom, Hyeon‐Seok Lee, Jeong‐Ok Kwon, Ji Hyun Han, Sang Hoon Lee, Seung‐Shin Kwak, Jae‐Yong Kim, Se Hyung Kim, Dae Sik Lee, Ji Hyun Oh, Sung Yong Ryoo, Hun Mo Kim, Hyo Jung Kim, Won Seog Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis |
| title | Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis |
| title_full | Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis |
| title_fullStr | Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis |
| title_full_unstemmed | Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis |
| title_short | Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis |
| title_sort | real‐world outcomes of ibrutinib therapy in korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968880/ https://www.ncbi.nlm.nih.gov/pubmed/33626235 http://dx.doi.org/10.1002/cac2.12150 |
| work_keys_str_mv | AT yijunho realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT kimseokjin realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT yoondokhyun realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT suhcheolwon realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT changmyunghee realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT yangdeokhwan realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT jojaecheol realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT hyunshinyoung realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT eomhyeonseok realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT leejeongok realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT kwonjihyun realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT hansanghoon realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT leeseungshin realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT kwakjaeyong realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT kimsehyung realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT kimdaesik realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT leejihyun realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT ohsungyong realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT ryoohunmo realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT kimhyojung realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis AT kimwonseog realworldoutcomesofibrutinibtherapyinkoreanpatientswithrelapsedorrefractorymantlecelllymphomaamulticenterretrospectiveanalysis |